Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  busulfan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 355 for your search:
Start Over
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: MCC-14178, NCT00361140
Treatment of Acute Myeloblastic Leukemia in Younger Patients
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715
LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040
Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation
Phase: Phase IV
Type: Biomarker/Laboratory analysis
Status: Enrolling by invitation
Age: 18 to 75
Sponsor: Other
Protocol IDs: BU-AdultPK/PGx1, NCT01071486
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816
Phase II/III Autologous Stem Cell Reinfusion Following ARA-C/BCNU for CML in Blast Crisis
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML
Stem Cell Transplant for Bone Marrow Failure Syndromes
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878
Prevention Chemotherapy Induced Mucositis by Zinc Sulfate
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: HORCSCT-0904, NCT01015183
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
Phase III Randomized Study of Autologous Bone Marrow vs G-CSF-Stimulated Peripheral Blood Stem Cell Transplantation for Advanced Breast Carcinoma (Summary Last Modified 05/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: no greater than 65
Sponsor: NCI
Protocol IDs: FHCRC-772.01, NCI-H94-0370
Phase III Randomized Study of IL-2 vs Observation Following Autologous Stem Cell Transplantation for Acute Myeloid Leukemia Beyond First Remission
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 60
Sponsor: NCI
Protocol IDs: SWOG-9328, E-S9328
Phase III Randomized, Placebo-Controlled Study of BU vs CTX as Adjuvant Therapy in Resectable Small and Nonsmall Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor:
Protocol IDs: MRC-LU02, EU-94017
Phase III Randomized Study of Rescue with CD34+ Selected vs Unselected Autologous PBSC Following High-Dose BU/CTX for Multiple Myeloma (Summary Last Modified 03/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-0060-002, NCI-V95-0712
Phase III Randomized Study of Unrelated Donor BMT vs Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia in First Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798
Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: Other
Protocol IDs: CDR0000065526, EORTC-06962, NCT00002989
Start Over